<h4>Background</h4>Inhibitor of NF-κB kinase-interacting protein (IKIP) is known to promote proliferation of glioblastoma (GBM) cells, but how it affects migration and invasion by those cells is unclear.<h4>Methods</h4>We compared levels of IKIP between glioma tissues and normal brain tissue in clinical samples and public databases. Here, IKBIP is linked to central nervous system cancer.